The effects of traditional medicine product in genital wart

Not Applicable

Conditions: Condition 1: Genital wart. Condition 2: Cervix dysplasia. Condition 3: vaginal dysplasia. Condition 4: papilloma of cervix.
Anogenital (venereal) warts
Mild cervical dysplasia
Mild vaginal dysplasia
Other benign neoplasms of uterus

Registration Number: IRCT2016092429936N1

Lead Sponsor: Vice Chancellor for Research and Technology Mashhad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Female patient with vaginal or cervical wart; age between 18 to 50 years Exclusion criteria: patient with Candida, trichomona and other infections vaginitis or cervicitis; patients with recognized immunodeficiency or autoimmune disease; HIV positive patients; Long-term use of corticosteroids or immunosuppressive; smoking; pregnancy; those who had CIN2 and CIN3 in cervix biopsy; Lack of satisfaction in every stage of the study

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HPV virus. Timepoint: Baseline, the end of the study. Method of measurement: HPV-PCR test.;Lesion size. Timepoint: Baseline,the end of the study. Method of measurement: Colposcopy.

Secondary Outcome Measures

Name	Time	Method
Clinical symptom. Timepoint: Baseline,end of the first and the second and the third month of the study. Method of measurement: According to the patient's symptoms.;Drug Side Effects. Timepoint: During the study. Method of measurement: According to the patient's symptoms.